The glucagonoma syndrome.
作者信息
Bloom S R, Sonksen P H
出版信息
J R Soc Med. 1990 Jan;83(1):60. doi: 10.1177/014107689008300135.
Abstract
摘要
相似文献
1
The glucagonoma syndrome.胰高血糖素瘤综合征
J R Soc Med. 1990 Jan;83(1):60. doi: 10.1177/014107689008300135.
2
The glucagonoma syndrome.胰高血糖素瘤综合征
J R Soc Med. 1990 Feb;83(2):127.
3
Treatment of inoperable glucagonoma with the long-acting somatostatin analogue SMS 201-995.使用长效生长抑素类似物SMS 201-995治疗无法手术切除的胰高血糖素瘤。
N Engl J Med. 1986 Jun 26;314(26):1686-9. doi: 10.1056/NEJM198606263142606.
4
Effect of somatostatin on skin lesions and concentrations of plasma amino acids in a patient with glucagonoma-syndrome.生长抑素对一名胰高血糖素瘤综合征患者皮肤病变及血浆氨基酸浓度的影响。
Hepatogastroenterology. 1988 Feb;35(1):34-7.
5
Octreotide (SMS 201-995) in the treatment of metastatic glucagonoma: report of one case and review of the literature.奥曲肽（SMS 201-995）治疗转移性胰高血糖素瘤：1例报告并文献复习
Digestion. 1989;42(2):116-20. doi: 10.1159/000199835.
6
Response of glucagonoma syndrome to lomustine.胰高血糖素瘤综合征对洛莫司汀的反应。
Cancer Treat Rep. 1986 Mar;70(3):433-4.
7
Glucagonoma and dacarbazine.胰高血糖素瘤与达卡巴嗪
Ann Intern Med. 1982 Dec;97(6):930. doi: 10.7326/0003-4819-97-6-930_1.
8
9
Vipoma, glucagonoma and the role of Sandostatin.血管活性肠肽瘤、胰高血糖素瘤与善得定的作用
NATNEWS. 1989 Jul;26(7):15.
10
Successful treatment of metastatic glucagonoma with dacarbazine.用达卡巴嗪成功治疗转移性胰高血糖素瘤。
Lancet. 1984 Mar 17;1(8377):621-2. doi: 10.1016/s0140-6736(84)91011-0.
Zotero 插件